Zhichao Deng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhichao Deng has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Hao Wu
NHC Key Laboratory of Forensic Science, Department of Forensic Pathology, College of Forensic Medicine, Xi'an Jiaotong University, 76 Yanta West Road, Xi'an, 710061, People's Republic of China
1 shared publicationJing Liu
NHC Key Laboratory of Forensic Science, Department of Forensic Pathology, College of Forensic Medicine, Xi'an Jiaotong University, 76 Yanta West Road, Xi'an, 710061, People's Republic of China
1 shared publicationKai Zhang
NHC Key Laboratory of Forensic Science, Department of Forensic Pathology, College of Forensic Medicine, Xi'an Jiaotong University, 76 Yanta West Road, Xi'an, 710061, People's Republic of China
1 shared publicationLetong Zhang
NHC Key Laboratory of Forensic Science, Department of Forensic Pathology, College of Forensic Medicine, Xi'an Jiaotong University, 76 Yanta West Road, Xi'an, 710061, People's Republic of China
1 shared publication- Mingzhen Zhang
Department of Pharmacology School of Basic Medical Sciences Xi'an Jiaotong University Xi'an Shaanxi China
1 shared publication - Ruina Liu
NHC Key Laboratory of Forensic Science, Department of Forensic Pathology, College of Forensic Medicine, Xi'an Jiaotong University, 76 Yanta West Road, Xi'an, 710061, People's Republic of China
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 1 January 2026
- Published by Ivyspring International Publisher in Theranostics
- Vol. 16 (4) , 1855-1876
Pharmacologically inherited carbon dots from Salvia miltiorrhiza with potent antioxidant activity and multi-pathway modulation for myocardial ischemia-reperfusion injury therapy
Rationale: Myocardial ischemia-reperfusion (I/R) injury remains a major clinical challenge that limits the efficacy of reperfusion therapy in acute myocardial infarction, mainly due to excessive production of reactive oxygen species (ROS) and the resulting oxidative stress, inflammation, and cardiomyocyte death. However, conventional antioxidant strategies show limited clinical efficacy, highlighting the urgent need for novel redox-regulating therapies.
- 1 January 2026
- Published by Ivyspring International Publisher in Theranostics
- Vol. 16 (4) , 1855-1876
Top Cited PapersOpen AccessPharmacologically inherited carbon dots from Salvia miltiorrhiza with potent antioxidant activity and multi-pathway modulation for myocardial ischemia-reperfusion injury therapy
Rationale: Myocardial ischemia-reperfusion (I/R) injury remains a major clinical challenge that limits the efficacy of reperfusion therapy in acute myocardial infarction, mainly due to excessive production of reactive oxygen species (ROS) and the resulting oxidative stress, inflammation, and cardiomyocyte death. However, conventional antioxidant strategies show limited clinical efficacy, highlighting the urgent need for novel redox-regulating therapies.